CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 45 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $77,000 | -78.5% | 10,500 | -79.3% | 0.00% | – |
Q3 2017 | $358,000 | -28.4% | 50,764 | -28.9% | 0.00% | – |
Q2 2017 | $500,000 | +2.9% | 71,354 | +1.8% | 0.00% | – |
Q1 2017 | $486,000 | +20.0% | 70,090 | -4.9% | 0.00% | – |
Q4 2016 | $405,000 | +6.3% | 73,690 | -3.3% | 0.00% | – |
Q3 2016 | $381,000 | +14.1% | 76,190 | +2.7% | 0.00% | – |
Q2 2016 | $334,000 | -4.8% | 74,190 | -5.1% | 0.00% | – |
Q1 2016 | $351,000 | -18.2% | 78,190 | -4.2% | 0.00% | – |
Q4 2015 | $429,000 | -12.1% | 81,640 | -3.6% | 0.00% | – |
Q3 2015 | $488,000 | -19.5% | 84,690 | 0.0% | 0.00% | – |
Q2 2015 | $606,000 | +2.5% | 84,690 | -4.5% | 0.00% | – |
Q1 2015 | $591,000 | +83.5% | 88,640 | +64.6% | 0.00% | – |
Q4 2014 | $322,000 | +21.1% | 53,840 | 0.0% | 0.00% | – |
Q3 2014 | $266,000 | +1.5% | 53,840 | -7.6% | 0.00% | – |
Q2 2014 | $262,000 | -2.2% | 58,240 | -2.2% | 0.00% | – |
Q1 2014 | $268,000 | -10.4% | 59,540 | +1.9% | 0.00% | – |
Q4 2013 | $299,000 | +12.8% | 58,420 | -0.3% | 0.00% | – |
Q3 2013 | $265,000 | -44.9% | 58,600 | -37.8% | 0.00% | – |
Q2 2013 | $481,000 | – | 94,150 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
Renaissance Technologies | 555,763 | $1,050 | 0.00% |
Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
BlackRock Inc. | 110,990 | $209,771 | 0.00% |
Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
Citadel Advisors | 32,400 | $61,236 | 0.00% |
Citadel Advisors | 6,400 | $12,096 | 0.00% |
Citadel Advisors | 5,933 | $11,213 | 0.00% |